Literature DB >> 24269151

Glycotherapy: new advances inspire a reemergence of glycans in medicine.

Jason E Hudak1, Carolyn R Bertozzi2.   

Abstract

The beginning of the 20(th) century marked the dawn of modern medicine with glycan-based therapies at the forefront. However, glycans quickly became overshadowed as DNA- and protein-focused treatments became readily accessible. The recent development of new tools and techniques to study and produce structurally defined carbohydrates has spurred renewed interest in the therapeutic applications of glycans. This review focuses on advances within the past decade that are bringing glycan-based treatments back to the forefront of medicine and the technologies that are driving these efforts. These include the use of glycans themselves as therapeutic molecules as well as engineering protein and cell surface glycans to suit clinical applications. Glycan therapeutics offer a rich and promising frontier for developments in the academic, biopharmaceutical, and medical fields.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24269151      PMCID: PMC4111574          DOI: 10.1016/j.chembiol.2013.09.010

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  276 in total

Review 1.  Synthetic glycopeptides and glycoproteins as tools for biology.

Authors:  Matthew R Pratt; Carolyn R Bertozzi
Journal:  Chem Soc Rev       Date:  2004-12-13       Impact factor: 54.564

Review 2.  Glycoprotein synthesis: an update.

Authors:  David P Gamblin; Eoin M Scanlan; Benjamin G Davis
Journal:  Chem Rev       Date:  2009-01       Impact factor: 60.622

Review 3.  Glycobiology.

Authors:  T W Rademacher; R B Parekh; R A Dwek
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  An engineered eukaryotic protein glycosylation pathway in Escherichia coli.

Authors:  Juan D Valderrama-Rincon; Adam C Fisher; Judith H Merritt; Yao-Yun Fan; Craig A Reading; Krishan Chhiba; Christian Heiss; Parastoo Azadi; Markus Aebi; Matthew P DeLisa
Journal:  Nat Chem Biol       Date:  2012-03-25       Impact factor: 15.040

5.  Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

Authors:  M H Tao; S L Morrison
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

6.  Site-selective glycosylation of hemoglobin with variable molecular weight oligosaccharides: potential alternative to PEGylation.

Authors:  Thomas J Styslinger; Ning Zhang; Veer S Bhatt; Nicholas Pettit; Andre F Palmer; Peng G Wang
Journal:  J Am Chem Soc       Date:  2012-04-21       Impact factor: 15.419

7.  Glycolipid-bound sialic acid in serum: increased levels in mice and humans bearing mammary carcinomas.

Authors:  T M Kloppel; T W Keenan; M J Freeman; D J Morré
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

8.  The influence of ligand valency on aggregation mechanisms for inhibiting bacterial toxins.

Authors:  Cristina Sisu; Andrew J Baron; Hilbert M Branderhorst; Simon D Connell; Carel A G M Weijers; Renko de Vries; Edward D Hayes; Aliaksei V Pukin; Michel Gilbert; Roland J Pieters; Han Zuilhof; Gerben M Visser; W Bruce Turnbull
Journal:  Chembiochem       Date:  2009-01-26       Impact factor: 3.164

9.  Chemical approaches to perturb, profile, and perceive glycans.

Authors:  Nicholas J Agard; Carolyn R Bertozzi
Journal:  Acc Chem Res       Date:  2009-06-16       Impact factor: 22.384

10.  PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES.

Authors:  C M Macleod; R G Hodges; M Heidelberger; W G Bernhard
Journal:  J Exp Med       Date:  1945-11-30       Impact factor: 14.307

View more
  57 in total

Review 1.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

2.  Glycosylation-related genes in NS0 cells are insensitive to moderately elevated ammonium concentrations.

Authors:  Arthur Nathan Brodsky; Mary Caldwell; Sooneon Bae; Sarah W Harcum
Journal:  J Biotechnol       Date:  2014-07-23       Impact factor: 3.307

3.  Chemical polyglycosylation and nanolitre detection enables single-molecule recapitulation of bacterial sugar export.

Authors:  Lingbing Kong; Andrew Almond; Hagan Bayley; Benjamin G Davis
Journal:  Nat Chem       Date:  2016-04-18       Impact factor: 24.427

Review 4.  Oligosaccharide Synthesis and Translational Innovation.

Authors:  Larissa Krasnova; Chi-Huey Wong
Journal:  J Am Chem Soc       Date:  2019-02-18       Impact factor: 15.419

Review 5.  Endoglycosidases for the Synthesis of Polysaccharides and Glycoconjugates.

Authors:  Chao Li; Lai-Xi Wang
Journal:  Adv Carbohydr Chem Biochem       Date:  2016-08-23       Impact factor: 12.200

6.  Cutting back on the carbs.

Authors:  Vivian H Trang; Peter D Senter
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-01       Impact factor: 11.205

7.  Specific Identification of Glycoproteins Bearing the Tn Antigen in Human Cells.

Authors:  Jiangnan Zheng; Haopeng Xiao; Ronghu Wu
Journal:  Angew Chem Int Ed Engl       Date:  2017-05-17       Impact factor: 15.336

Review 8.  Chemoenzymatic Methods for the Synthesis of Glycoproteins.

Authors:  Chao Li; Lai-Xi Wang
Journal:  Chem Rev       Date:  2018-08-24       Impact factor: 60.622

9.  Cell-Surface Glyco-Engineering by Exogenous Enzymatic Transfer Using a Bifunctional CMP-Neu5Ac Derivative.

Authors:  Chantelle J Capicciotti; Chengli Zong; M Osman Sheikh; Tiantian Sun; Lance Wells; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2017-09-15       Impact factor: 15.419

10.  Assembly of a Complex Branched Oligosaccharide by Combining Fluorous-Supported Synthesis and Stereoselective Glycosylations using Anomeric Sulfonium Ions.

Authors:  Wei Huang; Qi Gao; Geert-Jan Boons
Journal:  Chemistry       Date:  2015-08-06       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.